ClinicalTrials.gov
public full text
Public Domain
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects With Refractory Lupus Nephritis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus#321686
- Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus#907049
- CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors#1030391
- Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT#862229
- Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains.#323046
Record · ID 847923
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive